Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F3TI
|
||||
| Former ID |
DIB004478
|
||||
| Drug Name |
PT-630
|
||||
| Synonyms |
Non insulin dependent diabetes therapy, DARA BioSciences; Non insulin dependent diabetes therapy, Point Therapeutics
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Terminated | [548125] | ||
| Company |
DARA BioSciences Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Modulator | [556264] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.